eClinical Technology Adoption and Challenges in Study Startup

eClinical Technology Adoption and Challenges in Study Startup
The Tufts Center for the Study of Drug Development (CSDD) START II research, completed in 2017, indicated that clinical operations teams "satisfied" with their processes and those outperforming their competitors were adopters of technology.

But what is the extent of this technology adoption in site collaboration? And is this adoption serving as a catalyst for other organizational changes, such as interdepartmental collaboration (i.e., breaking down silos), outsourcing oversight, etc? Or are organizations simply "automating" manual processes without realizing the true operational benefits that technology can bring?

The new study, conducted by ISR Reports, focused on the diffusion of eClinical technology in the study startup phase of clinical trials including; site selection, patient recruitment, contracting and process optimization, application implementation and integration, and outsourcing.

The study comprises data from 262 respondents, 67% pharma and biotech 29% CROs with ~47% of respondents having more than 10 years in clinical development/clinical operations.

Areas examined in the research include:

  • eClinical technology in study startup usage & future deployments
  • Barriers to adopting eClinical solutions in study startup
  • Change management in study startup technology projects
  • Effectiveness of study startup technology implementations